Literature DB >> 24760274

Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.

Li-Jun Miao1, Feng-Xiang Huang, Zhen-Tao Sun, Rui-Xia Zhang, Shi-Fu Huang, Jing Wang.   

Abstract

Recent studies have shown that Beclin 1, a key regulator of autophagic process, is frequently downregulated and may serve as an independent prognostic biomarker for nonsmall cell lung cancer. However, the molecular mechanisms underlying its downregulation remain poorly understood. The signal transducer and activator of transcription 3 (Stat3) is a transcription factor which plays a crucial role for multiple tumor growth and progression. Here, we demonstrate that Beclin 1 is a direct transcriptional target of Stat3 in lung cancer cells. Interleukin-6 (IL-6) treatment or transfection of a constitutively activated Stat3 in AGS and NCI-H1650 cells inhibited Beclin 1 expression. At the molecular level, we further revealed that Stat3 could directly bind to the promoter region of Beclin 1 and repressed its transcription through recruiting histone deacetylase 3 (HDAC3). Collectively, our results suggest that the activated Stat3 may represent an important mechanism for Beclin 1 downregulation in nonsmall cell lung cancer development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760274     DOI: 10.1007/s13277-014-1961-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung.

Authors:  Yoshihiro Minamiya; Takashi Ono; Hajime Saito; Naoko Takahashi; Manabu Ito; Satoru Motoyama; Junichi Ogawa
Journal:  Tumour Biol       Date:  2010-06-19

2.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Authors:  Jiehui Deng; Yong Liu; Heehyoung Lee; Andreas Herrmann; Wang Zhang; Chunyan Zhang; Shudan Shen; Saul J Priceman; Maciej Kujawski; Sumanta K Pal; Andrew Raubitschek; Dave S B Hoon; Stephen Forman; Robert A Figlin; Jie Liu; Richard Jove; Hua Yu
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

Review 4.  Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Authors:  Hua Yu; Marcin Kortylewski; Drew Pardoll
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

Review 5.  The Beclin 1 network regulates autophagy and apoptosis.

Authors:  R Kang; H J Zeh; M T Lotze; D Tang
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

6.  STAT3 repressed USP7 expression is crucial for colon cancer development.

Authors:  Zhi Yang; Shoujun Huo; Yuanzhou Shan; Haijun Liu; Yume Xu; Kai Yao; Xianwei Li; Xueli Zhang
Journal:  FEBS Lett       Date:  2012-06-27       Impact factor: 4.124

Review 7.  Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferation.

Authors:  Alessandra Dicitore; Michele Caraglia; Germano Gaudenzi; Gloria Manfredi; Bruno Amato; Daniela Mari; Luca Persani; Claudio Arra; Giovanni Vitale
Journal:  Biochim Biophys Acta       Date:  2013-12-01

8.  Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Biao Li; Yun Chen; Xingcong Ren; Chang-Gong Liu; Jin-Ming Yang
Journal:  Autophagy       Date:  2009-08-20       Impact factor: 16.016

9.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

Review 10.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

View more
  21 in total

1.  The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells.

Authors:  Laurence Booth; Jane L Roberts; Peter Samuel; Francesca Avogadri-Connors; Richard E Cutler; Alshad S Lalani; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2018-03-06       Impact factor: 4.742

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 3.  A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.

Authors:  Yuhao Wang; Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2018

Review 4.  Autophagy and Hallmarks of Cancer.

Authors:  Tianzhi Huang; Xiao Song; Yongyong Yang; Xuechao Wan; Angel A Alvarez; Namratha Sastry; Haizhong Feng; Bo Hu; Shi-Yuan Cheng
Journal:  Crit Rev Oncog       Date:  2018

Review 5.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

6.  STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells.

Authors:  Sujoy Bhattacharya; Jinggang Yin; Chuanhe Yang; Yinan Wang; Michelle Sims; Lawrence M Pfeffer; Edward Chaum
Journal:  J Cell Mol Med       Date:  2022-06-06       Impact factor: 5.295

Review 7.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Beclin-1 as a neutrophil-specific immune checkpoint.

Authors:  Yu-Lin Su; Marcin Kortylewski
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

9.  JAK2/STAT3 inhibition attenuates intestinal ischemia-reperfusion injury via promoting autophagy: in vitro and in vivo study.

Authors:  Zhen Liu; Kai Hu; Yue-Sheng Chen; Ying-Jie Huang; Qian Hu; Wei Zeng; Yue Cao; Qin Xiao; Xue-Kang Zhang
Journal:  Mol Biol Rep       Date:  2022-01-24       Impact factor: 2.316

10.  Autophagy controls mesenchymal stem cell therapy in psychological stress colitis mice.

Authors:  Jun Tian; Xiaoxing Kou; Runci Wang; Huan Jing; Chider Chen; Jianxia Tang; Xueli Mao; Bingjiao Zhao; Xi Wei; Songtao Shi
Journal:  Autophagy       Date:  2020-09-17       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.